Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States.

Lopman BA, Curns AT, Yen C, Parashar UD.

J Infect Dis. 2011 Oct 1;204(7):980-6. doi: 10.1093/infdis/jir492. Epub 2011 Aug 29.

PMID:
21878425
2.

Unexpected benefits of rotavirus vaccination in the United States.

Glass RI.

J Infect Dis. 2011 Oct 1;204(7):975-7. doi: 10.1093/infdis/jir477. Epub 2011 Aug 29. No abstract available.

PMID:
21878426
3.

Cost effectiveness of a pentavalent rotavirus vaccine in Oman.

Al Awaidy ST, Gebremeskel BG, Al Obeidani I, Al Baqlani S, Haddadin W, O'Brien MA.

BMC Infect Dis. 2014 Jun 17;14:334. doi: 10.1186/1471-2334-14-334.

4.

Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, Lopman BA, Parashar UD; New Vaccine Surveillance Network (NVSN)..

Clin Infect Dis. 2011 Aug 1;53(3):245-53. doi: 10.1093/cid/cir307. Epub 2011 Jun 23.

PMID:
21705316
5.

Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.

Patel MM, Tate JE, Selvarangan R, Daskalaki I, Jackson MA, Curns AT, Coffin S, Watson B, Hodinka R, Glass RI, Parashar UD.

Pediatr Infect Dis J. 2007 Oct;26(10):914-9.

PMID:
17901797
6.

Nonmedical costs associated with rotavirus disease requiring hospitalization.

Lee BP, Azimi PH, Staat MA, Louie L, Parada E, Berke T, Ward RL, Bernstein DI, Matson DO.

Pediatr Infect Dis J. 2005 Nov;24(11):984-8.

PMID:
16282934
7.

The control of rotavirus gastroenteritis in the United States.

Glass RI, Parashar U, Patel M, Tate J, Jiang B, Gentsch J.

Trans Am Clin Climatol Assoc. 2012;123:36-52; discussion 53.

8.

Indirect protection and indirect measures of protection from rotavirus in adults.

Anderson EJ, Reddy S, Katz BZ, Noskin GA.

J Infect Dis. 2012 Jun;205(11):1762-4; author reply 1764-5. doi: 10.1093/infdis/jis262. Epub 2012 Mar 28. No abstract available.

PMID:
22457285
9.

Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine.

Tate JE, Curns AT, Cortese MM, Weintraub ES, Hambidge S, Zangwill KM, Patel MM, Baggs JM, Parashar UD.

Pediatrics. 2009 Mar;123(3):744-9. doi: 10.1542/peds.2008-1200.

PMID:
19254997
10.

Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil.

Fernandes EG, Sato HK, Leshem E, Flannery B, Konstantyner TC, Veras MA, Patel MM.

Vaccine. 2014 Jun 5;32(27):3402-8. doi: 10.1016/j.vaccine.2014.04.015. Epub 2014 Apr 13.

PMID:
24736002
11.

Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease.

Harris JP, Jit M, Cooper D, Edmunds WJ.

Vaccine. 2007 May 16;25(20):3962-70. Epub 2007 Mar 15.

PMID:
17395343
12.

All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009.

Desai R, Curns AT, Steiner CA, Tate JE, Patel MM, Parashar UD.

Clin Infect Dis. 2012 Aug;55(4):e28-34. doi: 10.1093/cid/cis443. Epub 2012 Apr 27.

PMID:
22543022
13.

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee. Erratum in: Pediatr Infect Dis J. 2011 Oct; 30(10):916.

PMID:
21183837
14.

Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?

Rheingans RD, Heylen J, Giaquinto C.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S48-55. Review.

PMID:
16397429
15.

An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model".

Tu HA, Rozenbaum MH, de Boer PT, Noort AC, Postma MJ.

BMC Infect Dis. 2013 Jan 30;13:54. doi: 10.1186/1471-2334-13-54.

16.

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.

Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H.

Vaccine. 2011 Mar 24;29(15):2791-6. doi: 10.1016/j.vaccine.2011.01.104. Epub 2011 Feb 12.

PMID:
21320539
17.

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD.

Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.

PMID:
19047240
18.

Effects of vaccine on rotavirus disease in the pediatric population.

Dennehy PH.

Curr Opin Pediatr. 2012 Feb;24(1):76-84. doi: 10.1097/MOP.0b013e32834ee594. Review.

PMID:
22189398
19.

Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program.

Dey A, Wang H, Menzies R, Macartney K.

Med J Aust. 2012 Oct 15;197(8):453-7.

PMID:
23072242
20.

Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.

Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD.

Expert Rev Vaccines. 2014 Mar;13(3):365-76. doi: 10.1586/14760584.2014.877846. Epub 2014 Jan 6. Review.

PMID:
24392657

Supplemental Content

Support Center